80
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Association of REarranged during Transfection (RET) c.73 + 9277T > C and c.135G > a Polymorphisms with Susceptibility to Hirschsprung Disease: A Systematic Review and Meta-Analysis

, , , , , , & show all
Pages 476-490 | Received 21 Aug 2019, Accepted 09 Sep 2019, Published online: 07 Oct 2019

References

  • Rochadi Haryana SM, Sadewa AH, G. Effect of RET c.2307T > G polymorphism on the outcomes of posterior sagittal neurectomy for hirschsprung disease procedure in an Indonesian population. Int Surg. 2014;99:802–806..
  • Zhang Y, He Q, Zhang R, Zhang H, Zhong W, Xia H. Large-scale replication study identified multiple independent SNPs in RET synergistically associated with Hirschsprung disease in Southern Chinese population. Aging. 2017;9:1996–2009. doi:10.18632/aging.101294.
  • Moore SW. Total colonic aganglionosis and Hirschsprung’s disease: a review. Pediatr Surg Int. 2015;31:1–9. doi:10.1007/s00383-014-3634-3.
  • Xie X, He Q, Huang L, Li L, Yao Y, Xia H, Zhao J, Zhong W, Zhang Y. Associations of SLC6A20 genetic polymorphisms with Hirschsprung’s disease in a Southern Chinese population. Biosci Rep. 2019;39.pii: BSR20182290 doi:10.1042/BSR20182290.
  • Jiang Q, Ho YY, Hao L, Berrios CN, Chakravarti A. Copy number variants in candidate genes are genetic modifiers of Hirschsprung disease. PLoS One. 2011;6:e21219. doi:10.1371/journal.pone.0021219.
  • Mulligan LM. GDNF and the RET receptor in cancer: new insights and therapeutic potential. Front Physiol. 2019;9:1873. doi:10.3389/fphys.2018.01873.
  • Ibáñez CF. Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Bio. 2013;5. pii: a009134
  • Bae JS, Koh I, Cheong HS, Seo J-M, Kim D-Y, Oh J-T, Kim H-Y, Jung K, Sul JH, Park W-Y, et al. A genome-wide association analysis of chromosomal aberrations and Hirschsprung disease. Trans Res. 2016;177:31–40.e6. doi:10.1016/j.trsl.2016.06.001.
  • Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer. 2014;120:1920–31. doi:10.1002/cncr.28661.
  • de Pontual L, Pelet A, Trochet D, Jaubert F, Espinosa-Parrilla Y, Munnich A, et al. Mutations of the RET gene in isolated and syndromic Hirschsprung’s disease in human disclose major and modifier alleles at a single locus. J Med Genet. 2005;43:419–23. doi:10.1136/jmg.2005.040113.
  • Arnold S, Pelet A, Amiel J, Borrego S, Hofstra R, Tam P, Ceccherini I, Lyonnet S, Sherman S, Chakravarti A, et al. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome–Hirschsprung disease association. Hum Mutat. 2009;30:771–75. doi:10.1002/humu.20944.
  • Miao X, Leon TY-Y, Ngan ES-W, So M-T, Yuan Z-W, Lui VC-H, Chen Y, Wong KK-Y, Tam PK-H, Garcia-Barceló M, et al. Reduced RET expression in gut tissue of individuals carrying risk alleles of Hirschsprung’s disease. Hum Mol Genet. 2010;19:1461–67. doi:10.1093/hmg/ddq020.
  • Phusantisampan T, Sangkhathat S, Phongdara A, Chiengkriwate P, Patrapinyokul S, Mahasirimongkol S. Association of genetic polymorphisms in the RET-protooncogene and NRG1 with Hirschsprung disease in Thai patients. J Hum Genet. 2012;57:286–93. doi:10.1038/jhg.2012.18.
  • Prato AP, Musso M, Ceccherini I, Mattioli G, Giunta C, Ghiggeri GM, Jasonni V. Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT). Medicine. 2009;88:83–90. doi:10.1097/MD.0b013e31819cf5da.
  • Zhang Z, Jiang Q, Li Q, Cheng W, Qiao G, Xiao P, Gan L, Su L, Miao C, Li L, et al. Genotyping analysis of 3 RET polymorphisms demonstrates low somatic mutation rate in Chinese Hirschsprung disease patients. Int J Clin Exp Pathol. 2015;8:5528–5534.
  • Gunadi Dwihantoro A, Iskandar K, Makhmudi A, Rochadi. Accuracy of polymerase chain reaction–restriction fragment length polymorphism for RET rs2435357 genotyping as Hirschsprung risk. J Surg Res. 2016;203:914.
  • Li Q, Zhang Z, Diao M, Gan L, Cheng W, Xiao P, Su L, Shangguan S, Jiang Q, Li L, et al. Cumulative risk impact of RET, SEMA3, and NRG1 polymorphisms associated with Hirschsprung disease in Han Chinese. J Pediatr Gastroenterol Nutr. 2017;64:385–90. doi:10.1097/MPG.0000000000001263.
  • Zhang X-N, Zhou M-N, Qiu Y-Q, Ding S-P, Qi M, Li J-C. Genetic analysis of RET, EDNRB, and EDN3 genes and three SNPs in MCS + 9.7 in Chinese patients with isolated Hirschsprung disease. Biochem Genet. 2007;45:523–27. doi:10.1007/s10528-007-9093-y.
  • Fitze G, Appelt H, König IR, Görgens H, Stein U, Walther W, et al. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet. 2003;12:3207–14. doi:10.1093/hmg/ddg354.
  • Garcia-Barcelo M, Ganster RW, Lui VCH, Leon TYY, So M-T, Lau AMF, Fu M, Sham M-H, Knight J, Zannini MS, et al. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung’s disease. Hum Mol Genet. 2005;14:191–204. doi:10.1093/hmg/ddi015.
  • Burzynski GM, Nolte IM, Osinga J, Ceccherini I, Twigt B, Maas S, Brooks A, Verheij J, Menacho IP, Buys CH, et al. Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2. Eur J Hum Genet. 2004;12:604–12. doi:10.1038/sj.ejhg.5201199.
  • Xiansheng Z, Ying Z, Ya G, Quan X, Yitao D, Xinkui G, et al. The relationship between Hirschsprung disease and single nucleotide polymorphisms of c135 in RET proto-oncogene. J Xi’an Jiaotong Univ (Med Sci). 2005;26:470–72.
  • Du H, Wang G, Zhang Y, Tao K, Tang S, Niu Y. [Association between RET proto-oncogene polymorphisms and Hirschsprung disease in Chinese Han population of Hubei district]. Zhonghua Wei Chang Wai Ke Za Zhi = Chin J Gastrointest Surg. 2006;9:152–56.
  • Liu C, Jin L, Li H, Lou J, Luo C, Zhou X, Li J-C. RET polymorphisms and the risk of Hirschsprung’s disease in a Chinese population. J Hum Genet. 2008;53:825–33. doi:10.1007/s10038-008-0315-x.
  • Saryono S, Rochadi R, Lestariana W, Artama WT, Sadewa AH. RET single nucleotide polymorphism in Indonesians with sporadic Hirschsprung’s disease. Univ Med. 2016;29:71–77.
  • Liu C-P, Tang Q-Q, Lou J-T, Luo C-F, Zhou X-W, Li D-M, Chen F, Li X, Li J-C. Association analysis of the RET proto-oncogene with Hirschsprung disease in the Han Chinese population of southeastern China. Biochem Genet. 2010;48:496–503. doi:10.1007/s10528-010-9333-4.
  • Tou J, Wang L, Liu L, Wang Y, Zhong R, Duan S, Liu W, Xiong Q, Gu Q, Yang H, et al. Genetic variants in RET and risk of Hirschsprung’s disease in Southeastern Chinese: a haplotype-based analysis. BMC Med Genet. 2011;12:32. doi:10.1186/1471-2350-12-32.
  • Liang C, Ji D, Yuan X, Ren L, Shen J, Zhang H. RET and PHOX2B genetic polymorphisms and Hirschsprung’s disease susceptibility: a meta-analysis. PLoS One. 2014;9:e90091. doi:10.1371/journal.pone.0090091.
  • Aflatoonian M, Moghimi M, Akbarian-Bafghi MJ, Morovati-Sharifabad M, Jarahzadeh MH, Neamatzadeh H. Association of TNF-α-308G > A polymorphism with susceptibility to celiac disease: a systematic review and meta-analysis. Arq Gastroenterol. 2019;56:88–94. doi:10.1590/s0004-2803.201900000-20.
  • Moghimi M, Sobhan MR, Jarahzadeh MH, Morovati-Sharifabad M, Aghili K, Ahrar H, Zare-Shehneh M, Neamatzadeh H. Association of GSTM1, GSTT1, GSTM3, and GSTP1 genes polymorphisms with susceptibility to osteosarcoma: a case-control study and meta-analysis. Asian Pac J Cancer Prev. 2019;20:675–82. doi:10.31557/APJCP.2019.20.3.675.
  • Kamali M, Hamadani S, Neamatzadeh H, Mazaheri M, Zare Shehneh M, Modaress Gilani M, Haghighi F. Association of XRCC2 rs3218536 polymorphism with susceptibility of breast and ovarian cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2017;18:1743–49.
  • Yazdi MM, Jamalaldini MH, Sobhan MR, Jafari M, Mazaheri M, Zare-Shehneh M, et al. Association of ESRα Gene Pvu II T > C, XbaI A > G and BtgI G > A polymorphisms with knee osteoarthritis susceptibility: a systematic review and meta-analysis based on 22 case-control studies. Arch Bone Joint Surg. 2017;5:351–62.
  • Moghimi M, Kargar S, Jafari MA, Ahrar H, Jarahzadeh MH, Neamatzadeh H, Sadeghizadeh-Yazdi J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2018;19:3225–3231. doi:10.31557/APJCP.2018.19.11.3225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.